Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ann Thorac Surg. 2017 Jul 29;104(4):1221–1230. doi: 10.1016/j.athoracsur.2017.05.011

Figure 4.

Figure 4

Propensity-matched survival for pN0 atypical carcinoids by use of adjuvant chemotherapy, NCDB 2006–2011

Estimate Overall Surgery Alone Adjuvant Chemo P value
12-month survival 87.6% (80.4–95.5%) 87.9% (79.8–96.7%) 86.7% (71.1–100%)
60-month survival 72.8% (62.2–85.2%) 72.3% (60–87.2%) 73.3% (54–99.5%)
Median survival 95.7 months 95.7 months NA months 0.54
NCDB National Cancer Data Base, pN0 pathologically node negative